CDEK
← All trials

NCT05346354

Phase 2/Phase 3Interventional

Trials that are a combination of phases 2 and 3.

View on ClinicalTrials.gov ↗

Timeline

Start date
Jun 23, 2022
Primary completion
Mar 1, 2026
Completion date
Mar 30, 2028
First posted
Apr 26, 2022
Last posted
Nov 7, 2022
Enrollment
12
Arms / groups
1 / —
Source
AACT · ctgov ingestion

Sponsors

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.